The role of tumor necrosis factor in sepsis
- 1 January 1992
- journal article
- review article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 62 (1), S11-S17
- https://doi.org/10.1016/0090-1229(92)90036-n
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious PurpuraNew England Journal of Medicine, 1988
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.The Journal of Experimental Medicine, 1987
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.The Journal of Experimental Medicine, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Distributions of cardiopulmonary variables in pediatric survivors and nonsurvivors of septic shockCritical Care Medicine, 1985
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- THE THERAPEUTIC VALUE OF THE MIXED TOXINS OF THE STREPTOCOCCUS OF ERYSIPELAS AND BACILLUS PRODIGIOSUS IN THE TREATEMENT OF INOPER- ABLE MALIGNANT TUMORSThe American Journal of the Medical Sciences, 1896
- CONTRIBUTION TO THE KNOWLEDGE OF SARCOMAAnnals of Surgery, 1891